The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study. BMJ 2026. Discussion by:
Guest:
Susan Kucher, MD
Program Director - Abington Family Medicine Residency Program
Jefferson Health
2. Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes Results From the VESALIUS-CV Trial. JAMA. Discussion by:
Guest:
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney Kimmel Medical College Thomas Jefferson University
Associate Director - Family Medicine Residency Program
Jefferson Health – Abington
3. Prevalence of Youth Overweight, Obesity, and Severe Obesity. JAMA Network Open. Discussion by:
Guest:
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney Kimmel Medical College Thomas Jefferson University
Associate Director - Family Medicine Residency Program
Jefferson Health – Abington
4. A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide. New England Journal of Medicine 2026. Discussion by:
Guest:
Griffin Johnson, MD
Resident - Abington Family Medicine Residency Program
Jefferson Health
Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.
This Podcast Episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
España